Results 1 to 10 of about 169 (169)
Gut and Liver, 2011 The goal of antiviral therapy for patients with chronic hepatitis C virus (HCV) infection is to attain a sustained virologic response (SVR), which is defined as undetectable serum HCV-RNA levels at 6 months after the cessation of treatment. Major improvements in antiviral therapy for chronic hepatitis C have occurred in the past decade. The addition of
Raymond T. Chung, Jae Young Jang
openaire +4 more sources
BMJ, 2007 Hepatitis C infection is a treatable disease.1 Generally, people with chronic hepatitis C are relatively asymptomatic but risk progression over time to cirrhosis and its complications. Combination antiviral therapy with pegylated interferon and ribavirin achieves sustained virological response rates of 42-80% depending on genotype.2 In August 2006 the ...
Timothy J.S. Cross +2 more
openaire +3 more sources
Chronic Hepatitis C in the Pandemic
Klimik Dergisi/Klimik Journal, 2021 Corona virus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, affected all the world and has been a major cause for significant morbidity and mortality. COVID-19 represents with pulmonary manifestations, but in more than half of the cases, other organs, especially hepatic involvement, are observed ...
Süda Tekin +3 more
openaire +4 more sources
Chronic Hepatitis C with Cyanosis [PDF]
Case Reports in Hepatology, 2019 Background. There are multiple aetiologies for dyspnea in patients with liver disease, including pneumonia, pulmonary embolism, hepatic hydrothorax, portopulmonary syndrome, and hepatopulmonary syndrome. The aim of this paper is to emphasize the importance of early diagnosis and management of hepatopulmonary syndrome. Case Presentation.
Mahmood Alawainati +3 more
openaire +2 more sources
Management of chronic hepatitis C [PDF]
Postgraduate Medical Journal, 2005 AbstractHepatitis C virus (HCV) infection is transmitted primarily through percutaneous exposure to blood, and most infections are associated with injection drug use. Progression to chronic HCV occurs in 55% to 86% of infected people, and persistent infection is a major cause of cirrhosis, end stage liver disease, and hepatocellular carcinoma.
V. Lo Re, Jay R. Kostman
openaire +3 more sources
Eltrombopag in chronic hepatitis C
World Journal of Gastroenterology, 2014 Chronic hepatitis C is a public health problem worldwide. Unfortunately, not all patients may benefit from antiviral therapy due to thrombocytopenia. Its causes are represented by portal hypertension and platelet sequestration in the spleen, decreased serum levels or activity of thrombopoietin, the bone marrow suppression induced by hepatitis C virus ...
Romeo-Gabriel Mihaila +1 more
openaire +3 more sources
Thrombocytopenia in Chronic Hepatitis C [PDF]
Proceedings of Surabaya International Physiology Seminar, 2017 Hepatitis C is a disease caused by hepatitis C virus (HCV), which can cause liver cirrhosis and cancer. Chronic hepatitis C infection has extrahepatic manifestations, including thrombocytopenia. Patients with this disease have exhibited varied thrombocytopenia prevalence, with reported prevalence of more than 24%.
Arvi Dian Prasetia Nurwidda +10 more
openaire +2 more sources
Pharmacoeconomics applied to chronic hepatitis C [PDF]
Brazilian Journal of Infectious Diseases, 2006 Life expectancy has increased over the last century as it had never been before. This is the result of a combination of many favorable variables such as level of education, improved socio-economic environment and development of medicine. However, new improvements demand heavy investment. Thus, the incorporation of medical technology became a health and
Tatsch, Fernando Franciosi +2 more
openaire +6 more sources
Pityriasis rosea in chronic hepatitis C
Balkan Medical Journal, 2014 Dear Editor, The report on “Pityriasis rosea (PR) in chronic hepatitis C” is very interesting (1). Guner et al. (1) noted that this is “the first case of PR found in a patient with chronic hepatitis C while receiving Pegylated interferon (PEG-IFN) alpha 2b and ribavirin.” In fact, the cause of the existence of PR in hepatitis C is an interesting ...
Güner R. +3 more
openaire +6 more sources
Natural history of chronic hepatitis C [PDF]
Hepatology, 2002 Much controversy surrounds the issue of the natural history of hepatitis C virus (HCV) infection. Many authorities view the disease as inexorably progressive with a high probability of advancing over time to cirrhosis and occasionally hepatocellular carcinoma (HCC) and, therefore, likely to be responsible for causing death ...
openaire +4 more sources